Đang chuẩn bị liên kết để tải về tài liệu:
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Long-acting (LA) injectable antiretroviral therapy (ART) has been found non-inferior to daily oral ART in Phase 3 trials. LA ART may address key barriers to oral ART adherence and be preferable to daily pills for some people living with HIV. |